Luca Nassi

2.6k total citations
39 papers, 675 citations indexed

About

Luca Nassi is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luca Nassi has authored 39 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pathology and Forensic Medicine, 16 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luca Nassi's work include Lymphoma Diagnosis and Treatment (29 papers), Viral-associated cancers and disorders (9 papers) and CNS Lymphoma Diagnosis and Treatment (8 papers). Luca Nassi is often cited by papers focused on Lymphoma Diagnosis and Treatment (29 papers), Viral-associated cancers and disorders (9 papers) and CNS Lymphoma Diagnosis and Treatment (8 papers). Luca Nassi collaborates with scholars based in Italy, United States and Switzerland. Luca Nassi's co-authors include Luigi Rigacci, Alberto Bosi, Antonio Castagnoli, Umberto Vitolo, Francesco Merli, Renato Alterini, Valentina Carrai, Andrea Gallamini, Annibale Versari and Rosaria Sancetta and has published in prestigious journals such as Blood, Cancer and Annals of Oncology.

In The Last Decade

Luca Nassi

35 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luca Nassi Italy	13	516	214	211	193	170	39	675
Scot Sorensen United States	9	472 0.9×	53 0.2×	179 0.8×	260 1.3×	150 0.9×	10	602
Reyes Arranz Spain	14	513 1.0×	45 0.2×	96 0.5×	373 1.9×	64 0.4×	36	757
Leanne Berkahn New Zealand	12	255 0.5×	47 0.2×	124 0.6×	150 0.8×	72 0.4×	36	474
R Regnier Belgium	4	120 0.2×	117 0.5×	58 0.3×	305 1.6×	218 1.3×	15	581
T. Girinsky France	12	128 0.2×	137 0.6×	48 0.2×	250 1.3×	90 0.5×	22	574
Joachim Bæch Denmark	10	163 0.3×	59 0.3×	55 0.3×	118 0.6×	46 0.3×	29	403
Menachem Ben-Shahar Israel	14	307 0.6×	46 0.2×	155 0.7×	262 1.4×	138 0.8×	24	802
Estelle Thébaud France	14	108 0.2×	23 0.1×	158 0.7×	206 1.1×	312 1.8×	53	647
P. Salvador United States	7	620 1.2×	34 0.2×	202 1.0×	386 2.0×	171 1.0×	7	840
Andreas Puespoek Austria	10	300 0.6×	75 0.4×	70 0.3×	242 1.3×	192 1.1×	19	640

Countries citing papers authored by Luca Nassi

Since Specialization

Citations

This map shows the geographic impact of Luca Nassi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Nassi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Nassi more than expected).

Fields of papers citing papers by Luca Nassi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Nassi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Nassi. The network helps show where Luca Nassi may publish in the future.

Co-authorship network of co-authors of Luca Nassi

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Nassi. A scholar is included among the top collaborators of Luca Nassi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Nassi. Luca Nassi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bens, Susanne, et al.. (2025). “In situ” MYC rearrangement and amplification as a secondary change in a case of High-grade B cell lymphoma with 11q aberration. Annals of Hematology. 104(9). 4831–4836.

Linguanti, Flavia, Vittorio Miele, Francesco Mungai, et al.. (2024). Texture analysis of 18F‐FDG PET/CT and CECT: Prediction of refractoriness of Hodgkin lymphoma with mediastinal bulk involvement. Hematological Oncology. 42(2). e3261–e3261. 6 indexed citations

Antonello, Roberta Maria, Marco Coppi, Luca Nassi, et al.. (2023). Combination regimen of nirmatrelvir/ritonavir and molnupiravir for the treatment of persistent SARS-CoV-2 infection: A case report and a scoping review of the literature. International Journal of Infectious Diseases. 133. 53–56. 21 indexed citations

Barbetti, M., Flavia Linguanti, Francesco Mungai, et al.. (2023). Characterization of Mediastinal Bulky Lymphomas with FDG-PET-Based Radiomics and Machine Learning Techniques. Cancers. 15(7). 1931–1931. 15 indexed citations

Mencarini, Jessica, Silvia Bresci, Filippo Bartalesi, et al.. (2023). Orbital Infiltration in a Patient with Waldenström Macroglobulinemia: Need for Multidisciplinary Approach and Comparison with the Literature. Mediterranean Journal of Hematology and Infectious Diseases. 15(1). e2023028–e2023028.

Capone, Manuela, Benedetta Peruzzi, Boaz Palterer, et al.. (2022). Rapid evaluation of T cell clonality in the diagnostic work-up of mature T cell neoplasms: TRBC1-based flow cytometric assay experience. Translational Oncology. 26. 101552–101552. 11 indexed citations

Skrypets, Tetiana, Cristina Ferrari, Luca Nassi, et al.. (2021). 18F-FDG PET/CT Cannot Substitute Endoscopy in the Staging of Gastrointestinal Involvement in Mantle Cell Lymphoma. A Retrospective Multi-Center Cohort Analysis. Journal of Personalized Medicine. 11(2). 123–123. 2 indexed citations

Chiappella, Annalisa, Fary Diop, Claudio Agostinelli, et al.. (2021). Prognostic impact of TP53 mutation in newly diagnosed diffuse large B‐cell lymphoma patients treated in the FIL‐DLCL04 trial. British Journal of Haematology. 196(5). 1184–1193. 21 indexed citations

Anastasia, Antonella, Annalisa Chiarenza, Luigi Marcheselli, et al.. (2019). Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL). British Journal of Haematology. 185(4). 713–717. 18 indexed citations

10.

Rigacci, Luigi, Benedetta Puccini, Alessandro Broccoli, et al.. (2019). Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study. Annals of Hematology. 99(2). 283–291. 3 indexed citations

11.

Merli, Francesco, Federica Cavallo, Flavia Salvi, et al.. (2019). Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi. Journal of Geriatric Oncology. 11(1). 37–40. 15 indexed citations

12.

Puccini, Benedetta, Luca Nassi, Carla Minoia, et al.. (2017). Role of bone marrow biopsy in staging of patients with classical Hodgkin’s lymphoma undergoing positron emission tomography/computed tomography. Annals of Hematology. 96(7). 1147–1153. 11 indexed citations

13.

Rabascio, Cristina, Luca Nassi, Sara Steffanoni, et al.. (2010). A single dose of Pegfilgrastim versus daily Filgrastim to evaluate the mobilization and the engraftment of autologous peripheral hematopoietic progenitors in malignant lymphoma patients candidate for high-dose chemotherapy. Transfusion and Apheresis Science. 43(3). 321–326. 26 indexed citations

14.

Bertazzoni, Paola, Cristina Rabascio, Liliana Calabrese, et al.. (2010). Rituximab and subcutaneous cladribine in chronic lymphocytic leukemia for newly diagnosed and relapsed patients. Leukemia & lymphoma. 51(8). 1485–1493. 9 indexed citations

15.

Martinelli, Giovanni, Gerard E. Ryan, John F. Seymour, et al.. (2009). Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group. Annals of Oncology. 20(12). 1993–1999. 64 indexed citations

16.

Laszlò, Daniele, Giancarlo Pruneri, Giovanna Andreola, et al.. (2009). Tissue Microarrays in Diffuse Large B-Cell Lymphomas. International Journal of Surgical Pathology. 19(4). 417–424. 2 indexed citations

17.

Rigacci, Luigi, Umberto Vitolo, Luca Nassi, et al.. (2007). Positron emission tomography in the staging of patients with Hodgkin’s lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi. Annals of Hematology. 86(12). 897–903. 69 indexed citations

18.

Rigacci, Luigi, Luca Nassi, Silvia Mappa, et al.. (2007). Rituximab and chlorambucil as first-line treatment for low-grade ocular adnexal lymphomas. Annals of Hematology. 86(8). 565–568. 31 indexed citations

19.

Rigacci, Luigi, Silvia Mappa, Luca Nassi, et al.. (2007). Liposome‐encapsulated doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab in patients with lymphoma and concurrent cardiac diseases or pre‐treated with anthracyclines. Hematological Oncology. 25(4). 198–203. 47 indexed citations

20.

Rigacci, Luigi, Valentina Carrai, Luca Nassi, et al.. (2005). Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non‐Hodgkin lymphoma. Cancer. 103(5). 970–977. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact